Articles include:
Origins of mosaicism and criteria for the transfer of mosaic embryos
Santiago Munné
Patients with a high proportion of immature and meiotically resistant oocytes experience defective nuclear oocyte maturation patterns and impaired pregnancy outcomes
Yuechao Lu, Minerva Ferrer-Buitrago, Mina Popovic, Jitesh Neupane, Winnok H. De Vos, Sylvie Lierman, Etienne Van den Abbeel, Margot Van der Jeught, Dimitra Nikiforaki, Petra De Sutter, Björn Heindryckx
Poor ovarian response as a predictor for live birth in older women undergoing IVF
Yoni Cohen, Samer Tannus, Nabigah Alzawawi, Weon-Young Son, Michael Dahan, William Buckett
A demographic projection of the contribution of assisted reproductive technologies to world population growth
Malcolm J. Faddy, Matthew D. Gosden, Roger G. Gosden
Articles include:
‘Man Up’: the importance and strategy for placing male reproductive health centre stage in the political and research agenda
Christopher L R Barratt; Christopher J De Jonge; Richard M Sharpe
Origin and composition of cell-free DNA in spent medium from human embryo culture during preimplantation development
M Vera-Rodriguez; A Diez-Juan; J Jimenez-Almazan; S Martinez; R Navarro; V Peinado; A Mercader; M Meseguer; D Blesa; I Moreno; D Valbuena; C Rubio; C Simon
The significance of human spermatozoa vacuoles can be elucidated by a novel procedure of array comparative genomic hybridization
Arie Berkovitz; Yaron Dekel; Revital Goldstein; Shhadeh Bsoul; Yossy Machluf; Dani Bercovich
This is an announcement of a brief study on blastocyst grading. This is a collaborative research project between the Department of Psychological Medicine, University of Auckland and Fertility Associates Auckland. The purpose of the survey is to examine some of the factors involved in embryologists’ decisions to freeze borderline quality blastocysts.
The survey is comprised of around 80 questions and should take less than 30 minutes. Participation is voluntary and all responses are anonymous. The study is sponsored by Fertility Associates, New Zealand.
Fertility treatment in the UK is more successful and safer than ever before, according to a report from the HFEA (Human Fertilisation and Embryology Authority).
IVF is now 85 percent more likely to succeed than when records first began in 1991, said the regulator. Over 20,000 babies were born in 2016 as a result of more than 68,000 IVF treatments, an increase of four percent from 2015. The HFEA's new report covers fertility treatment trends and success rates for the 2014-2016 period.
The UK's Human Fertilisation and Embryology Authority has said that it will halt funding for the Donor Conceived Register from the end of May.
The register has facilitated voluntary contact between people in the UK conceived through donated sperm or egg before 1991 and their donors, allowing them to exchange information or get in touch if they wish.
The Bath and North East Somerset CCG (Clinical Commissioning Group) has said that it will restrict IVF access to couples where the male partner has a body mass index (BMI) of less than 30.
The Arizona House of Representatives is considering a bill that would mean a couple's cryopreserved embryos could still be used by one of the parties if they split.
Studies in humans and animals have found that certain antihistamines may affect testicular function in males.
A review of research on the topic, published in the journal Reproduction, found that in animal studies, antihistamines were likely to affect the production of male sex hormones in the testes. This could lead to altered morphology and decreased motility of sperm, as well as a lower sperm count.
British people are largely in favour of using genome editing to prevent inheritance of genetic disorders, according to a survey by the Royal Society.
The development of improved methods for editing DNA mean a wider range of applications are now available to treat and cure serious diseases. The public's views on whether these technologies should be used in a clinical setting have, until now, been largely unknown.
A person's death need no longer spell the end of his or her future reproductive possibilities. A dead or dying person can have their reproductive tissue removed to enable someone else to have a child.
